Anti-fucosylceramide monoclonal antibody

Details Anti-fucosylceramide monoclonal antibody Anti-fucosylceramide monoclonal antibody

C - Chemistry, Metallurgy

07

K

167/37, 195/1.11

C07K 16/30 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2002530

-1- Abstract of the Disclosure HOE 88/S 050 A monoclonal antibody PC47H specifically recognizing fucosylceramide derived from a ceramide-mono-glycoside fraction of neutral glycolipid extracted and purified from human cancer tissues and having properties such as belonging to IgM and showing reactivity to neither of normal peripheral blood lymphocyte, normal erythrocyte, normal fibroblast nor cell lines derived from leukemia, hepatoma, breast cancer and neuroblastoma but to cell lines derived from lung cancer, stomach cancer, colon cancer and pancreas cancer; a hybridoma having an ability to produce the aforementioned monoclonal antibody; a method for manufacturing the aforementioned monoclonal antibody which comprises immunizing an animal with a neutral glycolipid fraction extracted from human pancreas cancer, fusing animal cells with myeloma cells to generate hybridomas, cloning the hybridomas, selecting clones which produce monoclonal antibodies which specifically recognize fucosylceramide and then using the clones to manufacture the monoclonal antibody; and a diagnostic of cancers such as lung cancer, stomach cancer, colon cancer and pancreas cancer containing the aforementioned monoclonal antibody as an active component.

Affiliated with

Also associated with

Rating

Anti-fucosylceramide monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-fucosylceramide monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-fucosylceramide monoclonal antibody will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1388490